The Pediatric Electrolyte Solution Market is growing steadily due to the rising incidence of dehydration-related conditions such as diarrhea, vomiting, fever, and excessive sweating in children, especially in developing regions with limited access to clean water and healthcare. These solutions, including Oral Rehydration Salts (ORS), ready-to-drink beverages, and powdered forms, are vital for restoring electrolyte balance and preventing severe dehydration. Their use spans hospitals, home care, and outpatient treatments due to their convenience and effectiveness.

Pediatric Perfusion Market Size Was Valued at USD 561.2 Million in 2023, and is Projected to Reach USD 893.25 Million by 2032, Growing at a CAGR of 5.3% From 2024-2032.

The Pemetrexed Market refers to the manufacture, supply and consumption of pemetrexed as a chemotherapeutic agent that is prescribed mainly for NSCLC and mesothelioma.